Bionano Genomics, Inc.BNGO
| Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Product revenue | 11 | 9 | 6 | 12 | 20 | 27 |
---|
Service and other revenue | 537,562 | 655,064 | 2 | 6 | 7 | 9 |
---|
Total revenue | 12 | 10 | 9 | 18 | 28 | 36 |
---|
Product revenue | 9 | 6 | 5 | 11 | 16 | 20 |
---|
Service and other revenue | 149,284 | 272,454 | 919,729 | 4 | 6 | 6 |
---|
Total cost of revenue | 9 | 7 | 6 | 14 | 22 | 27 |
---|
Research and development | 9 | 9 | 10 | 22 | 49 | 54 |
---|
Selling, general and administrative | 14 | 20 | 31 | 58 | 89 | 93 |
---|
Total operating expenses | 24 | 29 | 41 | 81 | 138 | 225 |
---|
Goodwill impairment | - | - | - | - | - | 77 |
---|
Total operating expenses | 24 | 29 | 41 | 81 | 138 | 225 |
---|
Loss from operations | -20,415,085 | -25,874,906 | -38,551,322 | -77 | -132 | -215 |
---|
Interest income | - | - | - | 0 | 2 | 3 |
---|
Interest expense | 1 | 2 | 3 | 1 | 0 | 5 |
---|
Gain on forgiveness of Paycheck Protection Program Loan | - | - | - | 2 | - | - |
---|
Other income (expenses) | - | - | - | -0 | -0 | 3 |
---|
Loss on debt extinguishment | -342,164 | -1,333,496 | - | -2 | - | - |
---|
Loss on High Trail Agreement | - | - | - | - | - | 19 |
---|
Other income (expenses) | - | - | - | -0 | -0 | 3 |
---|
Total other income (expense) | 2 | -3,919,116 | -2,525,836 | -1 | 1 | -17 |
---|
Total other income (expense) | 2 | -3,919,116 | -2,525,836 | -1 | 1 | -17 |
---|
Loss before income taxes | -18,480,881 | -29,794,022 | -41,077,158 | -78 | -131 | -232 |
---|
Benefit (provision) for income taxes | 15,511 | 21,048 | 29,193 | -6 | 2 | 0 |
---|
Net loss | -18,496,392 | -29,815,070 | -41,106,351 | -72 | -133 | -232 |
---|
Earnings Per Share, Basic | - | - | - | - | -0.46 | -6.81 |
---|
Earnings Per Share, Diluted | - | - | - | - | -0.46 | -6.81 |
---|